FI956300A - Pyridatsinonijohdannaisia - Google Patents

Pyridatsinonijohdannaisia Download PDF

Info

Publication number
FI956300A
FI956300A FI956300A FI956300A FI956300A FI 956300 A FI956300 A FI 956300A FI 956300 A FI956300 A FI 956300A FI 956300 A FI956300 A FI 956300A FI 956300 A FI956300 A FI 956300A
Authority
FI
Finland
Prior art keywords
group
atom
alkyl group
pct
hydrogen atom
Prior art date
Application number
FI956300A
Other languages
English (en)
Swedish (sv)
Other versions
FI113963B (fi
FI956300A0 (fi
Inventor
Keizo Tanikawa
Akira Saito
Mitsuaki Hirotsuka
Ken-Ichi Shikada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of FI956300A publication Critical patent/FI956300A/fi
Publication of FI956300A0 publication Critical patent/FI956300A0/fi
Application granted granted Critical
Publication of FI113963B publication Critical patent/FI113963B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI956300A 1993-06-29 1995-12-28 Menetelmä terapeuttisesti käyttökelpoisten 3 (2H) -Pyridatsinonijohdannaisten valmistamiseksi FI113963B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP15919493 1993-06-29
JP15919493 1993-06-29
JP11272194 1994-05-26
JP11272194 1994-05-26
PCT/JP1994/001015 WO1995001343A1 (en) 1993-06-29 1994-06-24 Pyridazinone derivatives with pharmaceutical activity
JP9401015 1994-06-24

Publications (3)

Publication Number Publication Date
FI956300A true FI956300A (fi) 1995-12-28
FI956300A0 FI956300A0 (fi) 1995-12-28
FI113963B FI113963B (fi) 2004-07-15

Family

ID=26451823

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956300A FI113963B (fi) 1993-06-29 1995-12-28 Menetelmä terapeuttisesti käyttökelpoisten 3 (2H) -Pyridatsinonijohdannaisten valmistamiseksi

Country Status (22)

Country Link
US (2) US5728702A (fi)
EP (1) EP0706517B1 (fi)
KR (1) KR100255416B1 (fi)
CN (1) CN1044906C (fi)
AT (1) ATE172454T1 (fi)
AU (1) AU676341B2 (fi)
CA (1) CA2166326C (fi)
CZ (1) CZ289231B6 (fi)
DE (1) DE69414112T2 (fi)
DK (1) DK0706517T3 (fi)
ES (1) ES2124413T3 (fi)
FI (1) FI113963B (fi)
HU (1) HU221009B1 (fi)
IL (1) IL110040A (fi)
NO (1) NO306675B1 (fi)
NZ (1) NZ267510A (fi)
RO (1) RO114791B1 (fi)
RU (1) RU2138486C1 (fi)
SK (1) SK280786B6 (fi)
TW (1) TW408114B (fi)
UA (1) UA34481C2 (fi)
WO (1) WO1995001343A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223963B1 (hu) * 1994-01-25 2005-03-29 Nissan Chemical Industries Ltd. Piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
SK14742000A3 (sk) * 1998-03-31 2001-03-12 Nissan Chemical Industries, Ltd. Pyridazinónová hydrochloridová zlúčenina a spôsob jej prípravy
AU769589B2 (en) * 1999-11-11 2004-01-29 Nissan Chemical Industries Ltd. Process for producing benzylamine compound
JP2005507923A (ja) 2001-10-22 2005-03-24 ファイザー・プロダクツ・インク Ｃｃｒ１受容体アンタゴニスト活性を有するピペラジン誘導体
US20060080140A1 (en) * 2004-02-09 2006-04-13 Epic Systems Corporation System and method for providing a clinical summary of patient information in various health care settings
WO2010099388A1 (en) * 2009-02-27 2010-09-02 Indigo Pharmaceuticals Combinational use of a pde3 inhibitor and other agents
CN116768868B (zh) * 2023-08-15 2023-12-08 云南省药物研究所 一种哒嗪酮硫代衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265798A (en) * 1984-12-10 1990-02-13 Motoo Mutsukado 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
EP0201765B1 (en) * 1985-04-27 1991-09-18 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
HU198696B (en) * 1987-01-20 1989-11-28 Nissan Chemical Ind Ltd Process for producing 3/2h/-pyridazinon derivatives and pharmaceutical compositions containing them as active components
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
EP0482208B1 (en) * 1990-04-25 2000-07-19 Nissan Chemical Industries Ltd. Pyridazinone derivative
HU223963B1 (hu) * 1994-01-25 2005-03-29 Nissan Chemical Industries Ltd. Piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
CN1126470A (zh) 1996-07-10
ATE172454T1 (de) 1998-11-15
NO955328L (no) 1996-02-28
IL110040A0 (en) 1994-10-07
DE69414112D1 (de) 1998-11-26
SK162495A3 (en) 1996-11-06
CN1044906C (zh) 1999-09-01
SK280786B6 (sk) 2000-07-11
CA2166326A1 (en) 1995-01-12
NZ267510A (en) 1996-10-28
FI113963B (fi) 2004-07-15
KR100255416B1 (ko) 2000-05-01
US5728702A (en) 1998-03-17
RO114791B1 (ro) 1999-07-30
HU9503807D0 (en) 1996-02-28
HUT73483A (en) 1996-08-28
ES2124413T3 (es) 1999-02-01
KR960703401A (ko) 1996-08-17
EP0706517A1 (en) 1996-04-17
FI956300A0 (fi) 1995-12-28
AU6983394A (en) 1995-01-24
UA34481C2 (uk) 2001-03-15
US5929074A (en) 1999-07-27
TW408114B (en) 2000-10-11
CA2166326C (en) 2005-02-01
DK0706517T3 (da) 1999-06-28
NO306675B1 (no) 1999-12-06
EP0706517B1 (en) 1998-10-21
IL110040A (en) 2000-07-16
NO955328D0 (no) 1995-12-28
RU2138486C1 (ru) 1999-09-27
HU221009B1 (hu) 2002-07-29
DE69414112T2 (de) 1999-03-11
CZ289231B6 (cs) 2001-12-12
AU676341B2 (en) 1997-03-06
CZ329995A3 (en) 1996-04-17
WO1995001343A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
HUP0103884A2 (hu) Arilszulfonanilidkarbamid-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
FI956300A (fi) Pyridatsinonijohdannaisia
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
NO995638D0 (no) Heterobicykliske forbindelser til fremstilling av pyridonkarboksylsyrederivater
NO972938D0 (no) Farmasöytiske piperazinforbindelser
DE69719974D1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59604901D1 (de) Carbamoylcarbonsäureamide
DK0832079T3 (da) Antiiskæmiske hydroxylaminderivater og farmaceutiske sammensætninger
FR2757161B1 (fr) Diphenylalkyl-tetrahydropyridines
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
CO5031252A1 (es) Compuestos
DK0651747T3 (da) Carbostyrilderivater

Legal Events

Date Code Title Description
MA Patent expired